Literature DB >> 16637847

Compound heterozygous RDH5 mutations in familial fleck retina with night blindness.

Takaaki Hayashi1, Satoshi Goto-Omoto, Tomokazu Takeuchi, Tamaki Gekka, Yasuo Ueoka, Kenji Kitahara.   

Abstract

PURPOSE: To describe the clinical features and genetic analysis of a 3-year-old boy diagnosed with familial fleck retina with night blindness.
METHODS: The proband and his parents and grandparents were included. History, visual acuity and fundus examinations were evaluated. Bright-flash (rod-plus-cone) electroretinograms (ERGs) were recorded after 30 mins and 180 mins of dark adaptation. Mutation screening of the RDH5 gene encoding 11-cis retinol dehydrogenase was performed.
RESULTS: The parents noticed the proband's night blindness when he was 2 years old. Best corrected visual acuity was 1.0 in both eyes. Fundus examinations revealed numerous yellow-white flecks of varying size and shape throughout the midperipheral to far peripheral retina in both eyes. The distribution, size and shape of the flecks were comparable to those seen in familial fleck retina with night blindness, rather than fundus albipunctatus. The ERGs showed extremely diminished responses after 30 mins of dark adaptation, but there were substantial increases in the amplitudes of both a- and b-waves when recorded after 180 mins of dark adaptation. Although a total of 19 RDH5 mutations have been found only in patients with fundus albipunctatus, compound heterozygous mutations, p.V177G and p.L310delinsEV, whose combination has not been previously reported, were found in the proband. The asymptomatic parents and one of the grandparents each carried one of the mutations, consistent with autosomal recessive transmission.
CONCLUSION: Our study indicates that different mutations in the RDH5 gene can cause phenotypic variations of either fundus albipunctatus or familial fleck retina with night blindness.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16637847     DOI: 10.1111/j.1600-0420.2005.00575.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  6 in total

Review 1.  The retinal pigment epithelium in health and disease.

Authors:  J R Sparrow; D Hicks; C P Hamel
Journal:  Curr Mol Med       Date:  2010-12       Impact factor: 2.222

2.  174delG mutation in mouse MFRP causes photoreceptor degeneration and RPE atrophy.

Authors:  Joseph Fogerty; Joseph C Besharse
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-14       Impact factor: 4.799

3.  A novel mutation in RDH5 gene causes retinitis pigmentosa in consanguineous Pakistani family.

Authors:  Neelam Sultan; Irfan Ali; Shazia Anwer Bukhari; Shahid Mahmood Baig; Muhammad Asif; Muhammad Qasim; Muhammad Imran Naseer; Mahmood Rasool
Journal:  Genes Genomics       Date:  2018-02-03       Impact factor: 1.839

4.  Novel mutations in RDH5 cause fundus albipunctatus in two consanguineous Pakistani families.

Authors:  Muhammad Ajmal; Muhammad Imran Khan; Kornelia Neveling; Yar Muhammad Khan; Syeda Hafiza Benish Ali; Waqas Ahmed; Muhammad Safdar Iqbal; Maleeha Azam; Anneke I den Hollander; Rob W J Collin; Raheel Qamar; Frans P M Cremers
Journal:  Mol Vis       Date:  2012-06-13       Impact factor: 2.367

Review 5.  Fundus albipunctatus: review of the literature and report of a novel RDH5 gene mutation affecting the invariant tyrosine (p.Tyr175Phe).

Authors:  Anna Skorczyk-Werner; Przemysław Pawłowski; Marta Michalczuk; Alicja Warowicka; Anna Wawrocka; Katarzyna Wicher; Alina Bakunowicz-Łazarczyk; Maciej R Krawczyński
Journal:  J Appl Genet       Date:  2015-03-28       Impact factor: 3.240

6.  Characterization of GUCA1A-associated dominant cone/cone-rod dystrophy: low prevalence among Japanese patients with inherited retinal dystrophies.

Authors:  Kei Mizobuchi; Takaaki Hayashi; Satoshi Katagiri; Kazutoshi Yoshitake; Kaoru Fujinami; Lizhu Yang; Kazuki Kuniyoshi; Kei Shinoda; Shigeki Machida; Mineo Kondo; Shinji Ueno; Hiroko Terasaki; Tomokazu Matsuura; Kazushige Tsunoda; Takeshi Iwata; Tadashi Nakano
Journal:  Sci Rep       Date:  2019-11-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.